David Margolis, MD

Dr. Margolis is Professor of Medicine, Microbiology and Immunology, and Epidemiology at the University of North Carolina at Chapel Hill. A clinician, trialist, and molecular virologist, his laboratory studies the interactions of HIV with its host, aiming to translate lab bench discoveries to the clinic to aid in the treatment of HIV. He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the American Society of Clinical Investigation, an editorial board member of the journal of the International AIDS Society, AIDS, and member of the AIDS Research Advisory Committee of the NIH.

Nancie Archin, PhD

Dr. Archin received her BS at Stony Brook University, Stony Brook, NY and her PhD at the State University of Texas at San Antonio, TX, department of Microbiology and Immunology. Her research project involves the use of genetic and biochemical approaches to delineate the mechanisms of HIV-1 latency in latently-infected cell lines, and it also involves using novel reagents to target the HIV-1 LTR of latently infected resting CD4+ T-cells isolated from HIV patients.


Mary Catherine Bowman, MD, PhD






Manzoor Cheema, MS

Manzoor has a background in Veterinary Medicine from Pakistan, and he completed his Masters in Immunology from North Carolina State University in 2003. Currently he is working on HIV eradication study from human latently infected CD4 cells.



Shailesh Choudhary, MS, PhD





Daniel Cothran, BA

Daniel is a first-year MPH student in the Department of Health Behavior and Health Education at the University of North Carolina at Chapel Hill School of Public Health.



Kara Keedy





Daniel Parker